ZFIN Fish: smyd1b^tm123a/tm123a

ZFIN ID: ZDB-FISH-150901-1566

ZFIN ID: ZDB-FISH-150901-1566

Fish name:	smyd1b^{tm123a/tm123a}
Genotype:	smyd1b^{tm123a/tm123a}
Targeting Reagent:	none

HUMAN DISEASE MODELED by smyd1b^{tm123a/tm123a}
No data available

GENE EXPRESSION
Gene expression in smyd1b^{tm123a/tm123a}

RNA expression

Expressed Gene	Structure	Conditions	Figures
ckmb	skeletal muscle	standard conditions	Fig 8 from Prill et al., 2019
hsp90aa1.1	somite whole organism	standard conditions	Fig. 4 from Prill et al., 2015
myhc4	trunk musculature whole organism	standard conditions	Fig. 2 from Prill et al., 2015
myom1a	somite whole organism	standard conditions	Fig 8 from Prill et al., 2019
smyd1b	whole organism	standard conditions	Fig. 4 from Prill et al., 2015
smyhc1	trunk musculature whole organism	standard conditions	Fig. 2 from Prill et al., 2015
unc45b	somite whole organism	standard conditions	Fig. 4 from Prill et al., 2015

Protein expression

Antibody	Structure	Conditions	Figures
Ab1-myom	(not) fast muscle cell M band slow muscle cell sarcomere	chemical treatment by environment: tricaine	Fig 6 from Prill et al., 2019
Ab1-myom	(not) fast muscle cell sarcomere slow muscle cell	standard conditions	Fig 5 from Prill et al., 2019
Ab-F59	slow muscle cell	standard conditions	Fig. 3 from Prill et al., 2015
Ab-F310	(not) fast muscle cell skeletal muscle myofibril	standard conditions	Fig. 3 from Prill et al., 2015

Reporter gene expression No data available

PHENOTYPE
Phenotype in smyd1b^{tm123a/tm123a}

Phenotype	Conditions	Figures
anatomical system quality, abnormal	standard conditions	Fig. for (tm123a) from Phenotype Annotation (1994-2006)
blood circulation arrested, abnormal	standard conditions	Fig. 1 from Prill et al., 2015
eye decreased size, abnormal	standard conditions	Fig. 1 from Prill et al., 2015
fast muscle cell disorganized, abnormal	standard conditions	Fig. 1 from Prill et al., 2015
fast muscle cell M band ab1-myom labeling absent, abnormal	standard conditions	Fig 5 from Prill et al., 2019
fast muscle cell M band ab1-myom labeling absent, abnormal	chemical treatment by environment: tricaine	Fig 6 from Prill et al., 2019
fast muscle cell sarcomere ab1-myom labeling absent, abnormal	standard conditions	Fig 5 from Prill et al., 2019
fast muscle cell sarcomere ab1-myom labeling absent, abnormal	chemical treatment by environment: tricaine	Fig 6 from Prill et al., 2019
fast muscle cell sarcomere absent, abnormal	standard conditions	Fig. 1 from Prill et al., 2015
fast muscle cell skeletal muscle myofibril ab-f310 labeling absent, abnormal	standard conditions	Fig. 3 from Prill et al., 2015
fast muscle cell vacuole increased amount, abnormal	standard conditions	Fig. 1 from Prill et al., 2015
head malformed, abnormal	standard conditions	Fig. 1 from Prill et al., 2015
heart decreased size, abnormal	standard conditions	Fig. 1 from Prill et al., 2015
heart non-contractile, abnormal	standard conditions	Table 1 from Chen et al., 1996
heart quality, abnormal	standard conditions	Fig. for (tm123a) from Phenotype Annotation (1994-2006)
heart contraction arrested, abnormal	standard conditions	text only from Prill et al., 2015 Table 1 from Chen et al., 1996
larval locomotory behavior process quality, abnormal	standard conditions	Table 4 from Granato et al., 1996
locomotion decreased occurrence, abnormal	standard conditions	Fig. 1 from Prill et al., 2015
musculoskeletal movement disrupted, abnormal	standard conditions	Fig. for (tm123a) from Phenotype Annotation (1994-2006)
pericardium edematous, abnormal	standard conditions	Fig. 1 from Prill et al., 2015
sarcomerogenesis disrupted, abnormal	standard conditions	Fig. 3 from Prill et al., 2015
sarcomerogenesis process quality, abnormal	chemical treatment by environment: tricaine	Fig 6 from Prill et al., 2019
skeletal muscle ckmb expression increased amount, abnormal	standard conditions	Fig 8 from Prill et al., 2019
skeletal myofibril assembly disrupted, abnormal	standard conditions	Fig. 3 from Prill et al., 2015
slow muscle cell sarcomere morphology, abnormal	standard conditions	Fig. 1 from Prill et al., 2015
slow muscle cell vacuole increased amount, abnormal	standard conditions	Fig. 1 from Prill et al., 2015
somite unc45b expression increased amount, abnormal	standard conditions	Fig. 4 from Prill et al., 2015
somite hsp90aa1.1 expression increased amount, abnormal	standard conditions	Fig. 4 from Prill et al., 2015
somite myom1a expression increased amount, abnormal	standard conditions	Fig 8 from Prill et al., 2019
striated muscle cell development process quality, abnormal	chemical treatment by environment: tricaine	Fig 6 from Prill et al., 2019
striated muscle cell development process quality, abnormal	standard conditions	Fig 5 from Prill et al., 2019
thigmotaxis arrested, abnormal	standard conditions	text only from Prill et al., 2015
whole organism dead, abnormal	standard conditions	text only from Prill et al., 2015
whole organism smyd1b expression decreased amount, abnormal	standard conditions	Fig. 4 from Prill et al., 2015
whole organism decreased behavioural activity, abnormal	standard conditions	Table 4 from Granato et al., 1996
whole organism myom1a expression increased amount, abnormal	standard conditions	Fig 8 from Prill et al., 2019
whole organism hsp90aa1.1 expression increased amount, abnormal	standard conditions	Fig. 4 from Prill et al., 2015
whole organism unc45b expression increased amount, abnormal	standard conditions	Fig. 4 from Prill et al., 2015
whole organism lethal (sensu genetics), abnormal	standard conditions	Fig. for (tm123a) from Phenotype Annotation (1994-2006)
whole organism viability, abnormal	standard conditions	Table 1 from Chen et al., 1996

CITATIONS (8)